Subclinical Vasculitis as a Potential Mechanism to Explain the Heightened Cardiovascular Risk in Rheumatoid Arthritis
One decade ago, James Rudd, who also co-authored the present paper, published the results of the first prospective trial investigating 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for imaging of inflammatory changes in carotid artery disease in Circulation1. Since that time, FDG-PET has emerged as a powerful non-invasive technique to measure vascular inflammation due to atherosclerosis1-10.
- Received October 18, 2012.
- Accepted October 22, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited